Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN)
Tweet Send to a Friend
Citi 2Q10 SMID Biotech Earnings Preview: Adjusting Auxilium Pharmaceuticals (Nasdaq: AUXL), Dendreon (Nasdaq: DNDN) Models Ahead of Earnings; Expecting Rest ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE